Last updated: 2026-10-03 23:36:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Pulsenmore Ltd. (PLSM) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $2.20, with a market capitalization of $14.14M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.97 to $12.97. This page covers its latest market performance, valuation, price trends and company information.
$14.14M | |
$2.16 | |
$12.97 | |
$1.97 | |
$2.17 | |
20.18K | |
477.93K | |
-- | |
$12.97 | |
$1.97 | |
-- | |
-- |
Pulsenmore Ltd. (PLSM) last closed at $2.18 as of 2026-10-02 23:54:00, unchanged from the previous close of $2.18.
During the latest regular trading session, PLSM traded between $1.97 and $12.97, with a volume of 20.18K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Pulsenmore Ltd. (PLSM) moved from $2.57 to $2.20, representing a decline of 14.32% ($0.37).
The stock traded between $1.97 and $2.63 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.
The average daily volume was 50.76 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 2.2%
PLSM is currently trading at $2.20, placing it 2.2% of the way from its 52-week low of $1.97 to its 52-week high of $12.97. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Pulsenmore Ltd is an emerging medical device company engaged in the research, development, manufacturing, marketing, and sale of non-invasive portable ultrasound solutions for home use. Its products include the Pulsenmore ES and Pulsenmore FC, along with the early-stage Pulsenmore MC, collectively referred to as Pulsenmore Products, enabling remote ultrasound scans in gynecology and other fields such as pulmonary, cardiology, and urology through telemedicine. The Company operates in a single segment focused on developing and commercializing portable ultrasound technologies, with Israel contributing the majority of its revenue.
| Employees | 63 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Pulsenmore Ltd. (PLSM) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.